[Skip to Content]
[Skip to Content Landing]
Article
January 1976

6-Hydroxydopamine in Treatment of Open-Angle Glaucoma

Author Affiliations

From the University of Illinois Eye and Ear Infirmary, Chicago.

Arch Ophthalmol. 1976;94(1):41-47. doi:10.1001/archopht.1976.03910030007004
Abstract

• In patients with open-angle glaucoma, subconjunctival injection of 6-hydroxydopamine produced chemical sympathectomy and sensitization to topically applied epinephrine. Prior to entry into this study, all patients had intraocular pressures (IOPs) greater than 30 mm Hg and had not responded to maximal medical therapy. The 6-hydroxydopamine was prepared in an ascorbic acid-buffered solution and was well tolerated by the patients. After subconjunctival administration of 6-hydroxydopamine, the mean decrease in IOPs was 50% in the treated eyes and 5% in the contralateral eyes. Topical administration of 1% epinephrine to eyes injected with 6-hydroxydopamine resulted in a mean fall of IOP of 40% that persisted for as long as three months. Repeated subconjunctival injections of 6-hydroxydopamine renewed the pressurelowering effects and sensitization to topically applied epinephrine.

References
1.
Linner E, Prijot E:  Cervical sympathetic ganglionectomy and aqueous flow . Arch Ophthalmol 54:831-833, 1955.Article
2.
Langham ME, Taylor CB:  The influence of superior cervical ganglionectomy on intraocular dynamics . J Physiol 152:447-452, 1960.
3.
Sears ML, Barany EH:  Outflow resistance and adrenergic mechanisms: Effects of sympathectomy, N-(2-chloroethyl) dibenzylamine hydrochloride (dibenamine) and dichloroisoproterenol on the outflow resistance of the rabbit eye . Arch Ophthalmol 64:839-848, 1960.Article
4.
Barany EH:  Transient increase in outflow facility after superior cervical ganglionectomy in rabbits . Arch Ophthalmol 67:303-311, 1962.Article
5.
Barany EH:  Adrenergic effects on outflow facility , in Paterson G, Miller SJH, Paterson GD (eds): Drug Mechanisms in Glaucoma: The Filston Glaucoma Symposium . London, Churchill, 1966, p 41-47.
6.
Treister G, Barany EH:  Mydriasis and intraocular pressure decrease in the conscious rabbit after unilateral superior cervical ganglionectomy . Invest Ophthalmol 9:331-342, 1970.
7.
Holland MG, Mims JL, III:  Anterior segment chemical sympathectomy by 6-hydroxydopamine: I. Effect on intraocular pressure and facility of outflow . Invest Ophthalmol 10:120-143, 1971.
8.
Holland MG:  Treatment of glaucoma by chemical sympathectomy with 6-hydroxydopamine . Trans Am Acad Ophthalmol Otolaryngol 76:437-449, 1972.
9.
Holland MG:  Treatment of glaucoma by chemical sympathectomy with 6-hydroxydopamine , in Schumann HJ, Kroneberg G (eds): New Aspects of Storage and Release Mechanisms of Catecholamines. Bayer Symposium II, Grosse Ledda, 1969 . Berlin, Springer-Verlag, 1970, pp 130-142.
10.
De Champlain J, Nadeau R:  6-Hydroxydopamine, 6-hydroxydopa and degeneration of adrenergic nerves . Fed Proc 30:877-885, 1971.
11.
Knyihar E, Ristovsky K, Kalman G:  Chemical sympathectomy: Histochemical and submicroscopical consequences of 6-hydroxydopamine treatment in the rat iris . Experimentia 25:518-520, 1969.Article
12.
Tranzer JP, Thoenen H:  An electron microscopic study of selective, acute degeneration of sympathetic nerve terminals after administration of 6-hydroxydopamine . Experimentia 24:155-156, 1968.Article
13.
Adams RN, Murrill E, McCreery R, et al:  6-Hydroxydopamine: New oxidation mechanism . Eur Pharmacol 17:287-292, 1972.Article
14.
Moses RA: Adler's Physiology of the Eye: Clinical Application , ed 5. St. Louis, CV Mosby, 1970, pp 402-404.
15.
Thompson HS, Mensher JH:  Adrenergic mydriasis in Horner's syndrome: Hydroxyamphetamine test for diagnosis of postganglionic defects . Am J Ophthalmol 72:472-480, 1971.
16.
Cogan G: Neurology of the Ocular Muscles , ed 2. Springfield, Ill, CC Thomas Publishers, 1956, pp 177-183.
17.
Linner E:  The pressure-lowering effects of ascorbic acid in normal human eyes , in Rohen JW (ed): Structure of the Eye . Stuttgart, Schattauer-Verlag, 1965, p 273-283.
18.
Langham E, Diggs M:  Quantitative studies of the ocular response to norepinephrine . Exp Eye Res 13:161-171, 1972.Article
19.
Laties A, Jacobowitz D:  A histochemical study of the adrenergic and cholinergic innervation of the anterior segment of the rabbit eye . Invest Ophthalmol 3:592-600, 1964.
20.
Bill A:  Effects of norepinephrine, isoproterenol and sympathetic stimulation of aqueous humor dynamics in Vervet monkeys . Exp Eye Res 10:31-46, 1970.Article
21.
Hoffmann F:  Effect of noradrenalin on intraocular pressure and outflow in Cynomolgus monkeys . Exp Eye Res 7:369-382, 1968.Article
22.
Langham ME, Diggs E: The paradox of the pressure responses in animals and man to adrenergic agonists. Read before the Association for Research in Vision and Ophthalmology ARVO meeting. Sarasota, Fla, May 1973.
23.
Kupfer C:  Clinical significance of pseudofacility . Am J Ophthalmol 75:193-204, 1973.
×